DC maturation and function are not altered by melanoma-derived immunosuppressive soluble factors

Journal of Surgical Research

Volumn 176, Issue 1, 2012, Pages 301-308

  Baumgartner, Joel M ^a,c   Jordan, Kimberly R ^a   Hu, Ling Jia ^a   Wilson, Cara C ^b   Banerjee, Anirban ^a   McCarter, Martin D ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

3 dioxygenase (IDO); dendritic cells; immunosuppression; indoleamine 2; melanoma

Indexed keywords

CD14 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 12P70; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL FUNCTION; CELL INTERACTION; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IN VITRO STUDY; MELANOMA; MYELOID DENDRITIC CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; DENDRITIC CELLS; ENDOCYTOSIS; HUMANS; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MELANOMA; SUPPRESSOR FACTORS, IMMUNOLOGIC; T-LYMPHOCYTES;

EID: 84862004428     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.07.040     Document Type: Article

References (27)

1. R.M. Steinman, and Z.A. Cohn Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution J Exp Med 137 1973 1142
2. J. Banchereau, F. Briere, and C. Caux Immunobiology of dendritic cells Annu Rev Immunol 18 2000 767
3. N. Cools, P. Ponsaerts, and V.F. Van Tendeloo Balancing between immunity and tolerance: An interplay between dendritic cells, regulatory T cells, and effector T cells J Leukoc Biol 82 2007 1365
4. M. Ferrantini, I. Capone, and F. Belardelli Dendritic cells and cytokines in immune rejection of cancer Cytokine Growth Factor Rev 19 2008 93
5. J.C. Peng, R. Thomas, and K. Dredge Dendritic cell immunotherapy for melanoma Rev Recent Clin Trials 1 2006 87
6. A. Anichini, C. Vegetti, and R. Mortarini The paradox of T-cell-mediated antitumor immunity in spite of poor clinical outcome in human melanoma Cancer Immunol Immunother 53 2004 855
7. J.E. Talmadge, M. Donkor, and E. Scholar Inflammatory cell infiltration of tumors: Jekyll or Hyde Cancer Metastasis Rev 26 2007 373
8. E. Gottfried, M. Kreutz, and A. Mackensen Tumor-induced modulation of dendritic cell function Cytokine Growth Factor Rev 19 2008 65
9. I. Perrot, D. Blanchard, and N. Freymond Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stage J Immunol 178 2007 2763
10. W. Vermi, R. Bonecchi, and F. Facchetti Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas J Pathol 200 2003 255
11. A.H. Enk, H. Jonuleit, and J. Saloga Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma Int J Cancer 73 1997 309
12. J. Baumgartner, C. Wilson, and B. Palmer Melanoma induces immunosuppression by up-regulating FOXP3(+) regulatory T cells J Surg Res 141 2007 72
13. M.D. McCarter, J. Baumgartner, and G.A. Escobar Immunosuppressive dendritic and regulatory T Cells are upregulated in melanoma patients Ann Surg Oncol 10 2007 2854
14. J.M. Baumgartner, R. Gonzalez, and K.D. Lewis Increased survival from stage IV melanoma associated with fewer regulatory T Cells J Surg Res 154 2009 13
15. M. McCarter, J. Clarke, and D. Richter Melanoma skews dendritic cells to facilitate a T helper 2 profile Surgery 138 2005 321
16. C.P. Gray, P. Arosio, and P. Hersey Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells Blood 99 2002 3326
17. M. Jeras, M. Bergant, and U. Repnik In vitro preparation and functional assessment of human monocyte-derived dendritic cells-potential antigen-specific modulators of in vivo immune responses Transpl Immunol 14 2005 231
18. B. Jacobs, M. Wuttke, and C. Papewalis Dendritic cell subtypes and in vitro generation of dendritic cells Horm Metab Res 40 2008 99
19. D. Ganguly, K. Paul, and J. Bagchi Granulocyte-macrophage colony-stimulating factor drives monocytes to CD14low CD83+ DCSIGN- interleukin-10-producing myeloid cells with differential effects on T-cell subsets Immunology 121 2007 499
20. T.F. Tedder, and P.J. Jansen Isolation and generation of human dendritic cells Curr Protoc Immunol 7 2001 32.1
21. S. Dillon, S. Agrawal, and K. Banerjee Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance J Clin Invest 116 2006 916
22. M.C. Rissoan, V. Soumelis, and N. Kadowaki Reciprocal control of T helper cell and dendritic cell differentiation Science 283 1999 1183
23. P. Hubert, N. Jacobs, and J.H. Caberg The cross-talk between dendritic and regulatory T cells: Good or evil? J Leukoc Biol 2007
24. N.S. Wilson, D. El-Sukkari, and G.T. Belz Most lymphoid organ dendritic cell types are phenotypically and functionally immature Blood 102 2003 2187
25. M. Jefford, M. Schnurr, and T. Toy Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: Differential regulation of function by specific classes of physiologic stimuli Blood 102 2003 1753
26. Y. Osugi, S. Vuckovic, and D.N. Hart Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes Blood 100 2002 2858
27. W.J. Lesterhuis, E.H. Aarntzen, and I.J. De Vries Dendritic cell vaccines in melanoma: From promise to proof? Crit Rev Oncol Hematol 66 2008 118